PERINDOPRIL TERT-BUTLYAMINE/INDAPAMIDE SERVIER 8/2.5 mg/mg Tablets Irland - Englisch - HPRA (Health Products Regulatory Authority)

perindopril tert-butlyamine/indapamide servier 8/2.5 mg/mg tablets

les laboratoires servier - perindopril tert-butylamine, indapamide - tablets - 8/2.5 mg/mg - ace inhibitors and diuretics

MODAFINIL SPR modafinil 100 mg tablets blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

modafinil spr modafinil 100 mg tablets blister pack

arrotex pharmaceuticals pty ltd - modafinil, quantity: 100 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; methylcellulose - modafinil is indicated: ? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy; ? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate; ? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

TERTROXIN tablets Australien - Englisch - Department of Health (Therapeutic Goods Administration)

tertroxin tablets

aspen pharmacare australia pty ltd - liothyronine sodium, quantity: 20 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; acacia; sodium chloride; magnesium stearate - indications as at 01 jan 1991 : tertroxin is indicated in the treatment of : coma due to myxoedema; management of severe thyroid deficiency; hypothyroid states arising in treatment of thyrotoxicosis. tertroxin may be preferred for treating severe and acute hypothyroid states because of its rapid and more potent effect but thyroxine sodium is normally the drug of choice for routine replacement therapy. tertroxin can also be used therapeutically in the treatment of thyrotoxicosis as an adjunct to carbimazole in order to prevent sub-clinical hypothyroidism developing during treatment.